Finding 606769 (2022-001)

Significant Deficiency
Requirement
L
Questioned Costs
-
Year
2022
Accepted
2023-06-28

AI Summary

  • Core Issue: The reported expenses for PRF Period 2 were overstated due to a misinterpretation of reporting instructions, leading to a total of $5,947,568 instead of the correct $884,911.
  • Impacted Requirements: Compliance with HRSA reporting deadlines and maintaining effective internal controls as per 45 CFR 75, which ensures accurate financial reporting and management of federal awards.
  • Recommended Follow-Up: Enhance internal controls for PRF reporting to ensure accuracy, and submit the necessary adjustments in the next reporting period (Period 5) due by September 2023.

Finding Text

2022-001: Accuracy of PRF Reporting Grantor: Department of Health and Human Services Program Name: Provider Relief Fund Federal Award Year: October 1, 2021 through September 30, 2022 Federal Award Number: Not available Assistance Listing Number: 93.498 Criteria or Requirement PRF recipients that received one or more payments exceeding $10,000 in the aggregate during a Payment Received Period are required to report on several required data elements as part of the post-payment reporting process. Reporting must be completed and submitted to HRSA by the reporting dates specified by HRSA. Additionally, Title 45 U.S. Code of Federal Regulations Part 75 (45 CFR 75), Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards, section Title 45 U.S. Code of Federal Regulations Part 75 (45 CFR 75), Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards, section 03(a) states the non-Federal entity must establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in ?Standards for Internal Control in the Federal Government? issued by the Comptroller General of the United States or the ?Internal Control Integrated Framework?, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Condition Found, Including Perspective The dollar amount of expenses reported by management in the Health Resources and Services Administration (HRSA) portal Period 2 submission ($5,947,568) was incorrect. Management entered the total dollar amounts of expenses for Periods 1 and 2 rather than just the Period 2 expenses that should have been reported in the Period 2 submission. Period 2 expenses should have been $884,911. Possible Cause The condition found results from a misinterpretation of the PRF Reporting Period 2 submission. In completing the PRF Reporting Period 2, the HRSA website automatically populated certain PRF Reporting Period 1 data into the HRSA Reporting Period 2 portal. Management interpreted this to mean that unreimbursed COVID expenses are to be reported on a cumulative basis in the PRF Reporting Period 2 and therefore overstated unreimbursed expenses for Period 1. Effect Failure to ensure accuracy of amounts reported in the portal may result in HRSA relying on incomplete or inaccurate information associated to the Institute?s utilization of PRF funds. Questioned Costs None Statistical Validity The sample was not intended to be, and was not, a statistically valid sample. Repeat Finding from the Prior Year No. Recommendation We recommend the Institute enhance its internal controls over PRF reporting to ensure each of the data elements reported to HRSA are accurate and result in amounts consistent with its underlying records. Views of Responsible Officials There was an error in PRF Reporting Period 2 due to a misinterpretation of the instructions, which resulted in the double counting of Period 1 expenses. When it was determined there was an error, the Institute immediately contacted HRSA to request re-opening of the Period 2 report to revise the reported expenses. HRSA did not allow for the re-opening of the reporting period and maintained that the adjustment should be submitted during the Institute?s next reporting period. The Institute will make the adjustment in its next reporting period, Period 5, due by September 2023. The adjustment will net down Period 1 expenses and remedy the double counting issue. As the correct interpretation of the instructions is now known to the Institute, the expenses will be reported to HRSA accurately and consistent with the Institute records moving forward.

Categories

Allowable Costs / Cost Principles Reporting Matching / Level of Effort / Earmarking Internal Control / Segregation of Duties

Other Findings in this Audit

  • 30327 2022-001
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.498 Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $22.52M
21.027 Coronavirus State and Local Fiscal Recovery Funds $5.91M
93.879 Medical Library Assistance $322,134
81.086 Conservation Research and Development $306,343
93.310 Trans-Nih Research Support $277,556
93.865 Child Health and Human Development Extramural Research $189,995
93.262 Occupational Safety and Health Program $177,233
93.867 Vision Research $173,891
93.397 Cancer Centers Support Grants $167,507
47.070 Computer and Information Science and Engineering $146,328
93.242 Mental Health Research Grants $109,743
93.838 Lung Diseases Research $104,358
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $102,186
93.121 Oral Diseases and Disorders Research $95,360
64.054 Research & Development $84,962
99.RD Contract $81,003
47.049 Mathematical and Physical Sciences $74,878
93.396 Cancer Biology Research $62,484
93.226 Research on Healthcare Costs, Quality and Outcomes $53,810
12.420 Military Medical Research and Development $48,374
93.399 Cancer Control $48,142
93.855 Allergy, Immunology and Transplantation Research $47,013
93.213 Research and Training in Complementary and Alternative Medicine $40,095
93.989 International Research and Research Training $36,895
93.361 Nursing Research $32,135
47.041 Engineering Grants $31,376
93.859 Biomedical Research and Research Training $27,240
93.393 Cancer Cause and Prevention Research $27,215
93.847 Diabetes, Endocrinology and Metabolism Research $25,596
93.279 Drug Abuse and Addiction Research Programs $18,129
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $17,033
93.172 Human Genome Research $16,192
93.866 Aging Research $15,617
81.049 Office of Science Financial Assistance Program $13,064
93.837 Heart and Vascular Diseases Research $12,801
93.286 Discovery and Applied Res for Tech Innovations $10,749
12.910 Research and Technology Development $10,155
93.395 Cancer Treatment Research $9,862
93.398 Cancer Research Manpower $4,173
12.300 Basic and Applied Scientific Research Dept of Defense $3,231
93.110 Maternal and Child Health Federal Consolidated Programs $1,116
93.839 Blood Diseases and Resources Research $591
93.389 National Center for Research Resources $584
93.350 National Center for Advancing Translational Sciences $-138
93.853 Extramural Res Prgms in Neurosciences and Neurological Disease $-625
93.394 Cancer Detection and Diagnosis Research $-661
93.135 Cntrs for Res and Demonstration for Hlth Promotino and Dis Prev $-670